Free Review Articles on Cardiomyopathy (hypertrophic)                                 Metatextbook

Freie Reviews über Kardiomyopathie (Hypertrophe)                                 Look here for Journal Homepages

  • Cardiomyopathy (hypertrophic)
  • Aortic valve (Stenosis and artificial valve)
  • Interventional cardiology
  • Heart (Echocardiography)
  • Coronary heart disease (NoReflow)
  • Heart (MRT)
  • MyBP C
  • MYH7
  • TNNI3
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12006Management of hypertrophic cardiomyopathy.



    		+-nlBMJ 332(7552):1251-5 (2006)
    22006Hypertrophic cardiomyopathy.



    		+-nlAnesthesiology 104(1):183-92 (2006)
    32006Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.



    		+-nlHeart 92(9):1339-44 (2006)
    42002Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.



    		+-nlHeart 87(2):169-76 (2002)
    52001Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.



    		+-nlHeart 86(6):709-14 (2001)
    61995How should we manage symptomatic aortic stenosis in the patient who is 80 or older?



    		+-nlBr Heart J 74(5):481-4 (1995)
    71994Natural history of hypertrophic cardiomyopathy.



    		+-nlBr Heart J 72(6 Suppl):S10-2 (1994)
    81990Hypertrophic cardiomyopathy: one disease or several?



    		+-nlBr Heart J 63(5):263-4 (1990)
    92008Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.



    		+-nlCurr Cardiol Rev 4(3):193-7 (2008)
    102007Intracardiac echocardiography guidance for alcohol septal ablation in hypertrophic obstructive cardiomyopathy.



    		+-nlJ Invasive Cardiol 19(5):E134-6 (2007)
    112009Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management.



    		+-nlEur J Echocardiogr 10(8):iii9-14 (2009)
    121999Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.



    		+-nlCardiovasc Res 44(1):20-36 (1999)
    132003Hypertrophic cardiomyopathy: from gene defect to clinical disease.



    		+-nlCell Res 13(1):9-20 (2003)
    141978[Classification of jaundice caused by intrahepatic cholestasis and etiopathogenetic considerations].



    		+-nlMinerva Chir 33(22):1647-52 (1978)
    151998Familial hypertrophic cardiomyopathy: from mutations to functional defects.



    		+-nlCirc Res 83(6):580-93 (1998)
    162008Management of symptoms in hypertrophic cardiomyopathy.



    		+-nlCirculation 117(3):429-39 (2008)
    172006A contemporary approach to hypertrophic cardiomyopathy.



    		+-nlCirculation 113(24):e858-62 (2006)
    182005Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy.



    		+-nlCirculation 112(2):293-6 (2005)
    191995Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.



    		+-nlCirculation 92(9):2488-95 (1995)
    201995Hypertrophic cardiomyopathy. Clinical spectrum and treatment.



    		+-nlCirculation 92(7):1680-92 (1995)
    212009Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.



    		+-nlEur Heart J 30(2):139-51 (2009)
    222006The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?



    		+-nlEur Heart J 27(16):1895-7 (2006) Maron BJ
    232003American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.



    		+-nlEur Heart J 24(21):1965-91 (2003)
    242003Hypertrophic cardiomyopathy-the clinical challenge of managing a hereditary heart condition.



    		+-nlEur Heart J 24(6):496-8 (2003)
    252000Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy.



    		+-nlEur Heart J 21(9):704-7 (2000)
    261999New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence.



    		+-nlEur Heart J 20(18):1292-4 (1999)
    272006The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.



    		+-nlHeart 92(9):1191-3 (2006) Harding SA
    282008Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm.



    		+-nlJ Am Coll Cardiol 52(7):567-8 (2008) Reichek N
    292002Hypertrophic cardiomyopathy: a systematic review.



    		+-nlJAMA 287(10):1308-20 (2002)
    301991Problems in diagnosis and management of hypertrophic cardiomyopathy.



    		+-nlPostgrad Med J 67(790):713-8 (1991)
    312009Contemporary treatment of hypertrophic cardiomyopathy.



    		+-nlTex Heart Inst J 36(3):194-204 (2009)
    321995Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.



    		+-nlTex Heart Inst J 22(2):126-33 (1995)
    331994Molecular basis of hypertrophic and dilated cardiomyopathy.



    		+-nlTex Heart Inst J 21(1):6-15 (1994)
    341979Nonobstructive and obstructive hypertrophic cardiomyopathies.



    		+-nlWest J Med 130(4):325-49 (1979)
    352007Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?



    		+-nlJ Am Coll Cardiol 50(9):831-4 (2007)
    362005The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.



    		+-nlJ Am Coll Cardiol 46(3):477-9 (2005) Watkins H
    372003American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.



    		+-nlJ Am Coll Cardiol 42(9):1687-713 (2003)
    382007MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances.



    		+-nlAJR Am J Roentgenol 189(6):1344-52 (2007)
    392007MRI of hypertrophic cardiomyopathy: part I, MRI appearances.



    		+-nlAJR Am J Roentgenol 189(6):1335-43 (2007)
    402007Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy.



    		+-nlMayo Clin Proc 82(12):1516-22 (2007)
    412008Identification of myofilament mutations: its role in the diagnosis and management of hypertrophic cardiomyopathy.



    		+-nlMayo Clin Proc 83(6):626-7 (2008)
    422005Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well.



    		+-nlCirculation 111(16):2016-8 (2005) Maron BJ
    432009The science of uncertainty and the art of probability: syncope and its consequences in hypertrophic cardiomyopathy.



    		+-nlCirculation 119(13):1697-9 (2009) Elliott P
    442008Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity.



    		+-nlCirculation 117(14):1775-7 (2008) Hilfiker-Kleiner D
    452010A decade of percutaneous septal ablation in hypertrophic cardiomyopathy.



    		+-nlCirc J 75(1):28-37 (2010)
    462010Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy.



    		+-nlEur Heart J 31(13):1551-3 (2010) Maron BJ
    472010DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.



    		+-nlEur Heart J 31(8):926-35 (2010)
    482008Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.



    		+-nlEur Heart J 29(9):1160-7 (2008)
    492011Genetic testing strategies for the diagnosis of hypertrophic cardiomyopathy.



    		+-nlRev Port Cardiol 30(1):19-23 (2011)
    502005Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.



    		+-nlRev Port Cardiol 24(12):1463-76 (2005)
    512005The enigmatic diversity of hypertrophic cardiomyopathy.



    		+-nlRev Port Cardiol 24(12):1479-84 (2005) Brito D
    522005Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?



    		+-nlRev Port Cardiol 24(9):1137-46 (2005)
    532010The role of cardiac magnetic resonance in hypertrophic cardiomyopathy.



    		+-nlRev Port Cardiol 29(1):79-93 (2010)
    542008Hypertrophic cardiomyopathy--state of the art in 2007.



    		+-nlRev Port Cardiol 27(5):625-37 (2008)
    552010Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.



    		+-nlEuropace 12(3):313-21 (2010)
    562011The diagnosis and treatment of hypertrophic cardiomyopathy.



    		+-nlDtsch Arztebl Int 108(13):209-15 (2011)
    572005Sudden death and hypertrophic cardiomyopathy: a review.



    		+-nlCan J Cardiol 21(5):441-8 (2005)
    582007Hypertrophic cardiomyopathy in children, teenagers and young adults.



    		+-nlHellenic J Cardiol 48(4):228-33 (2007)
    592009Alcohol septal ablation in hypertrophic obstructive cardiomyopathy.



    		+-nlHellenic J Cardiol 50(6):511-22 (2009)
    602007Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety.



    		+-nlSwiss Med Wkly 137(47-48):657-9 (2007)
    612008Diagnostic evaluation of hypertrophic cardiomyopathy in its clinical and preclinical phases.



    		+-nlArq Bras Cardiol 91(1):51-62 (2008)
    622009Pacemaker therapy in hypertrophic obstructive cardiomyopathy: still awaiting the evidence.



    		+-nlRev Esp Cardiol 62(11):1217-20 (2009)
    632002Phenotypic diversity in hypertrophic cardiomyopathy.



    		+-nlHum Mol Genet 11(20):2499-506 (2002)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.